188 related articles for article (PubMed ID: 30959120)
1. Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging.
Kratz JR; Haro GJ; Cook NR; He J; Van Den Eeden SK; Woodard GA; Gubens MA; Jahan TM; Jones KD; Kim IJ; He B; Jablons DM; Mann MJ
J Thorac Oncol; 2019 Jul; 14(7):1223-1232. PubMed ID: 30959120
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer.
Haro GJ; Sheu B; Cook NR; Woodard GA; Mann MJ; Kratz JR
JAMA Netw Open; 2019 Dec; 2(12):e1917062. PubMed ID: 31808928
[TBL] [Abstract][Full Text] [Related]
3. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
[TBL] [Abstract][Full Text] [Related]
4. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
Chen K; Chen H; Yang F; Sui X; Li X; Wang J
Clin Lung Cancer; 2017 Nov; 18(6):e457-e466. PubMed ID: 28539214
[TBL] [Abstract][Full Text] [Related]
6. A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.
Blaauwgeers H; Damhuis R; Lissenberg-Witte BI; de Langen AJ; Senan S; Thunnissen E
J Thorac Oncol; 2019 Mar; 14(3):459-467. PubMed ID: 30408568
[TBL] [Abstract][Full Text] [Related]
7. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
[TBL] [Abstract][Full Text] [Related]
8. Comparison of seventh TNM and eighth TNM staging system in stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy.
Yılmaz U; Özdemir Ö; Yılmaz Ü
Curr Probl Cancer; 2019 Feb; 43(1):33-42. PubMed ID: 29804944
[No Abstract] [Full Text] [Related]
9. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
Martínez-Terroba E; Behrens C; Agorreta J; Monsó E; Millares L; Felip E; Rosell R; Ramirez JL; Remirez A; Torre W; Gil-Bazo I; Idoate MA; de-Torres JP; Pio R; Wistuba II; Pajares MJ; Montuenga LM
Thorax; 2019 Apr; 74(4):371-379. PubMed ID: 30472670
[TBL] [Abstract][Full Text] [Related]
10. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
11. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
[TBL] [Abstract][Full Text] [Related]
12. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
[TBL] [Abstract][Full Text] [Related]
13. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years.
Xia J; Li H; Ji Y; Mi C; Chen G; Li P; Zhang R; Chen W; Wang J
Curr Probl Cancer; 2019 Aug; 43(4):363-370. PubMed ID: 30522775
[TBL] [Abstract][Full Text] [Related]
15. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
[TBL] [Abstract][Full Text] [Related]
17. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
[TBL] [Abstract][Full Text] [Related]
18. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.
Martínez-Terroba E; Behrens C; de Miguel FJ; Agorreta J; Monsó E; Millares L; Sainz C; Mesa-Guzman M; Pérez-Gracia JL; Lozano MD; Zulueta JJ; Pio R; Wistuba II; Montuenga LM; Pajares MJ
J Pathol; 2018 Aug; 245(4):421-432. PubMed ID: 29756233
[TBL] [Abstract][Full Text] [Related]
19. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
20. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]